Colfax Corp. (CFX) Tops Q3 EPS by 3c, Offers Q4 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
- Sysco calls on Teamsters to end LA strike after economic deal reached
Colfax Reports Third Quarter 2020 Results
October 29, 2020 6:00 AM EDTReported $0.12 EPS from continuing operations and achieved $0.41 of adjusted EPSImproved sales momentum with Medical Technology segment achieving 2% reported growth, and 1% organic growthFabrication Technology segment 21% decremental margin contributed to solid Company profit and cash flow performanceSigned definitive agreement to acquire extremity product lines with annual revenue of $20 million
ANNAPOLIS JUNCTION, MD, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Â Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its financial results for the third quarter of 2020.
The Company reported net income from continuing... More



